Revvity Net Profit Margin 2010-2024 | RVTY
Current and historical net profit margin for Revvity (RVTY) from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Revvity net profit margin for the three months ending June 30, 2024 was .
| Revvity Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-06-30 | $2.71B | $0.17B | 6.24% |
| 2024-03-31 | $2.73B | $0.15B | 5.50% |
| 2023-12-31 | $2.75B | $0.69B | 25.19% |
| 2023-09-30 | $2.80B | $0.74B | 26.54% |
| 2023-06-30 | $2.84B | $0.82B | 28.83% |
| 2023-03-31 | $3.02B | $0.96B | 31.78% |
| 2022-12-31 | $3.31B | $0.57B | 17.18% |
| 2022-09-30 | $3.00B | $0.63B | 21.03% |
| 2022-06-30 | $3.15B | $0.67B | 21.40% |
| 2022-03-31 | $3.48B | $0.74B | 21.28% |
| 2021-12-31 | $3.83B | $0.94B | 24.64% |
| 2021-09-30 | $3.63B | $1.13B | 31.19% |
| 2021-06-30 | $3.74B | $1.18B | 31.65% |
| 2021-03-31 | $3.32B | $1.07B | 32.33% |
| 2020-12-31 | $2.66B | $0.73B | 27.34% |
| 2020-09-30 | $3.23B | $0.41B | 12.77% |
| 2020-06-30 | $2.98B | $0.30B | 9.91% |
| 2020-03-31 | $2.89B | $0.23B | 7.86% |
| 2019-12-31 | $2.88B | $0.23B | 7.91% |
| 2019-09-30 | $2.84B | $0.23B | 8.25% |
| 2019-06-30 | $2.80B | $0.25B | 8.99% |
| 2019-03-31 | $2.78B | $0.25B | 8.88% |
| 2018-12-31 | $2.78B | $0.24B | 8.57% |
| 2018-09-30 | $2.66B | $0.13B | 4.73% |
| 2018-06-30 | $2.54B | $0.14B | 5.51% |
| 2018-03-31 | $2.39B | $0.28B | 11.73% |
| 2017-12-31 | $2.26B | $0.29B | 12.98% |
| 2017-09-30 | $2.18B | $0.40B | 18.29% |
| 2017-06-30 | $2.14B | $0.37B | 17.09% |
| 2017-03-31 | $2.13B | $0.23B | 10.61% |
| 2016-12-31 | $2.12B | $0.23B | 11.06% |
| 2016-09-30 | $2.00B | $0.24B | 11.86% |
| 2016-06-30 | $2.05B | $0.23B | 11.43% |
| 2016-03-31 | $2.08B | $0.22B | 10.55% |
| 2015-12-31 | $2.11B | $0.21B | 10.07% |
| 2015-09-30 | $2.10B | $0.18B | 8.35% |
| 2015-06-30 | $2.07B | $0.16B | 7.81% |
| 2015-03-31 | $2.07B | $0.16B | 7.89% |
| 2014-12-31 | $2.07B | $0.16B | 7.58% |
| 2014-09-30 | $2.22B | $0.19B | 8.70% |
| 2014-06-30 | $2.20B | $0.19B | 8.69% |
| 2014-03-31 | $2.18B | $0.17B | 7.74% |
| 2013-12-31 | $2.16B | $0.17B | 7.74% |
| 2013-09-30 | $2.13B | $0.08B | 3.94% |
| 2013-06-30 | $2.12B | $0.07B | 3.49% |
| 2013-03-31 | $2.10B | $0.08B | 3.81% |
| 2012-12-31 | $2.11B | $0.07B | 3.37% |
| 2012-09-30 | $2.08B | $0.00B | 0.14% |
| 2012-06-30 | $2.03B | $0.01B | 0.49% |
| 2012-03-31 | $1.98B | $0.01B | 0.30% |
| 2011-12-31 | $1.92B | $0.01B | 0.42% |
| 2011-09-30 | $1.85B | $0.39B | 21.02% |
| 2011-06-30 | $1.81B | $0.36B | 20.09% |
| 2011-03-31 | $1.76B | $0.39B | 22.34% |
| 2010-12-31 | $1.70B | $0.39B | 22.97% |
| 2010-09-30 | $1.54B | $0.13B | 8.53% |
| 2010-06-30 | $1.49B | $0.13B | 8.84% |
| 2010-03-31 | $1.51B | $0.10B | 6.36% |
| 2009-12-31 | $1.55B | $0.08B | 5.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.548B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.497B | 14.81 |
| Cencora (COR) | United States | $44.320B | 16.94 |
| ICON (ICLR) | Ireland | $23.561B | 21.17 |
| DiDi Global (DIDIY) | China | $23.282B | 0.00 |
| Avantor (AVTR) | United States | $17.560B | 26.63 |
| Natera (NTRA) | United States | $15.549B | 0.00 |
| Viatris (VTRS) | United States | $13.785B | 4.20 |
| CochLear (CHEOY) | Australia | $12.759B | 0.00 |
| Solventum (SOLV) | United States | $11.670B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.275B | 31.18 |
| Charles River Laboratories (CRL) | United States | $10.239B | 19.35 |
| Sonic Healthcare (SKHHY) | Australia | $9.066B | 0.00 |
| Doximity (DOCS) | United States | $7.965B | 50.47 |
| HealthEquity (HQY) | United States | $6.980B | 37.88 |
| Bausch + Lomb (BLCO) | Canada | $6.671B | 28.71 |
| PACS (PACS) | United States | $6.029B | 0.00 |
| Organon (OGN) | United States | $4.938B | 5.02 |
| Life Times (LTH) | United States | $4.827B | 40.35 |
| Sotera Health (SHC) | United States | $4.747B | 23.94 |
| Surgery Partners (SGRY) | United States | $4.058B | 44.96 |
| Concentras Parent (CON) | United States | $2.838B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.613B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.599B | 97.86 |
| BrightSpring Health Services (BTSG) | United States | $2.570B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.194B | 0.00 |
| Premier (PINC) | United States | $2.003B | 9.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.618B | 8.12 |
| CareDx (CDNA) | United States | $1.566B | 0.00 |
| Agilon Health (AGL) | United States | $1.539B | 0.00 |
| Progyny (PGNY) | United States | $1.517B | 26.67 |
| Teladoc Health (TDOC) | United States | $1.449B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.314B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.153B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| Pediatrix Medical (MD) | United States | $0.967B | 10.52 |
| Embecta (EMBC) | United States | $0.817B | 5.45 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.531B | 0.00 |
| Sharecare (SHCR) | United States | $0.524B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.466B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.346B | 13.00 |
| Sera Prognostics (SERA) | United States | $0.256B | 0.00 |
| Biodesix (BDSX) | United States | $0.248B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| ModivCare (MODV) | United States | $0.200B | 6.34 |
| Ascend Wellness Holdings (AAWH) | United States | $0.181B | 0.00 |
| Beauty Health (SKIN) | United States | $0.171B | 0.00 |
| MultiPlan (MPLN) | United States | $0.118B | 0.00 |
| Nutex Health (NUTX) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 22.49 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.087B | 0.00 |
| SBC Medicals (SBC) | United States | $0.050B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.032B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.031B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.029B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.018B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |